Zuid-Afrikaans Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bang, H
RWESpine, NCT05082090: A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices

Recruiting
N/A
2000
Europe, US, RoW
Spinal Surgery
Orthofix Inc.
Spinal Disorders/Injuries
12/31
12/31
Thobejane, E
RWESpine, NCT05082090: A Multi-Center Post-Market Data Collection Protocol to Evaluate the Performance of Orthofix Spine Devices

Recruiting
N/A
2000
Europe, US, RoW
Spinal Surgery
Orthofix Inc.
Spinal Disorders/Injuries
12/31
12/31
Mey, Larry
MARIO, NCT05178862: A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Suspended
3
220
Europe, Canada, US, RoW
SCY-078, Ibrexafungerp, Fluconazole, Diflucan, Echinocandin, Caspofungin, Micafungin, Anidulafungin
Scynexis, Inc.
Candidiasis, Invasive, Candidemia
06/24
08/24
NCT05298813: Phase 1/2 Study to Evaluate the Efficacy and Safety of Inhaled IBIO123 in Participants With Mild to Moderate COVID-19 Illness

Completed
1/2
162
RoW
IBIO123, Placebo
Immune Biosolutions Inc
COVID-19
01/23
01/23
NCT05303376: Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

Completed
1/2
123
RoW
IBIO123, Placebo
Immune Biosolutions Inc
COVID-19
06/23
06/23

Download Options